Rob Goldin

Chronic treatment with glucagon-like peptide-1 and glucagon receptor co-agonist causes weight loss-independent improvements in hepatic steatosis in mice with diet-induced obesity.

J. Minnion, Iona Davies, Stephen R. Bloom, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.